Nasogastric tube syndrome: A Meta-summary of case reports

Table 3 Clinical course of patients with nasogastric syndrome

Indication for NGT	Number of patients, n (%)
Acute stroke	10 (37.04)
Peri-operative period	7 (25.93)
Altered mental status	4 (14.81)
Gastrointestinal obstruction	2 (7.41)
Traumatic brain or spinal cord injury	2 (7.41)
GI bleed	1 (3.7)
Acute pancreatitis	1 (3.7)
Severe pneumonia with septic shock	1 (3.7)
Toxic megacolon	1 (3.7)
Presenting symptoms
Stridor	17 (62.96)
Sore throat/throat pain	7 (25.93)
Shortness of breath	4 (14.8)
Desaturation	3 (11.11)
Speech disturbance	4 (14.8)
Swallowing difficulty	3 (11.11)
Cough	1 (3.7)
Altered sensorium	1 (3.7)
Incidental	2 (7.41)
Type of feed NGT
Nasogastric	23 (85.19)
Long intestinal tube	1 (3.7)
Naso-intestinal ileus tube	2 (7.41)
NA	1 (3.7)
Vocal cord involved
Bilateral	21 (77.78)
Left	2 (7.41)
Right	2 (7.41)
Therapeutic interventions
Tube removal	21 (77.78)
Systemic steroids	7 (25.93)
Inhalational steroids	4 (14.81)
Frequent change of nasogastric tube	1 (3.7)
Tracheostomy procedure
Yes	17 (62.96)
No	8 (29.63)
NA	2 (7.41)
Final outcome
Alive	23 (85.19)
Dead	3 (11.11)
NA	1 (3.7)
Reported sequelae of NGT syndrome
Improved after 3 wk	4 (14.81)
Improved after 4 wk	2 (7.41)
Partial improvement after 4 wk	1 (3.7)
Improved after 5 wk	2 (7.41)
Improved after 8 wk	2 (7.41)
No recovery till 4 wk	1 (3.7)
Persistent vocal cord palsy	2 (7.41)
None reported	8 (29.63)

NG: Nasogastric; NGT: Nasogastric tube; NA: Not available; GI: Gastrointestinal.